GlassScriptPhysician profile
Joseph C Vineyard
NPI 1376723940
$5,949.49
in general payments reported to CMS, 2019-2025
14 companies · $645 in 2025
The $645 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $340 · 2020: $223 · 2021: $1,565 · 2022: $1,539 · 2023: $212 · 2024: $1,426 · 2025: $645.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,855 · Travel and Lodging: $427.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,855.24 |
| Travel and Lodging | $427.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,938.35 | 2021-2024 | |
| Pylant Medical | $1,787.57 | 2019-2024 | |
| Smith+Nephew, INC. | $829.25 | 2021-2025 | Cadence, Panta 2, Evos |
| Stryker Corporation | $352.67 | 2019-2025 | Variax, Infinity Adaptis, Incompass Total Ankle System |
| Integra Lifesciences Corporation | $284.01 | 2019-2020 | |
| Restor3d, INC. | $207.43 | 2024 | |
| Bioventus LLC | $202.09 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Wright Medical Technology, INC. | $121.88 | 2019-2020 | |
| Avanos Medical | $63.40 | 2025 | On-Q Pump and Accessories |
| Treace Medical Concepts, INC. | $63.31 | 2025 | |
| Ferring Pharmaceuticals INC. | $47.37 | 2025 | Euflexxa |
| Horizon Therapeutics Plc | $24.50 | 2020 | |
| Ossur Americas, INC. | $15.13 | 2025 | |
| Depuy Synthes Sales INC. | $12.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Vineyard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.